Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03517449
Brief Title: Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])

First Submitted : April 25, 2018
First Submitted that Met QC Criteria : April 25, 2018
First Posted : May 7, 2018

Results First Submitted : October 19, 2021
Results First Submitted that Met QC Criteria : October 19, 2021
Results First Posted : November 17, 2021

Last Update Submitted that Met QC Criteria : March 7, 2022
Last Update Posted : March 29, 2022